Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

463
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
463
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

23
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
23
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

747
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
747
Menopause01:28

Menopause

202
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
202
Nursing Assessment of the Genitourinary System I: Health History01:21

Nursing Assessment of the Genitourinary System I: Health History

30
The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...
30
Urodynamic Studies: Uroflowmetry01:19

Urodynamic Studies: Uroflowmetry

85
Uroflowmetry is a non-invasive urodynamic test designed to measure various aspects of urination, including volume, flow rate, and the time to void. This test is crucial for diagnosing and assessing conditions such as bladder outlet obstruction, bladder dysfunction, incomplete bladder emptying, incontinence, and urinary tract blockages caused by benign prostatic hyperplasia (BPH) and urethral strictures.Pre-Test Instructions:Before a uroflowmetry test, patients are typically advised to drink...
85

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pelvic Lymph Node Dissection in Prostate Cancer: Update from a Randomized Clinical Trial of Limited Versus Extended Dissection.

European urology·2024
Same author

Successful completion of large, low-cost randomized cancer trials at an academic cancer center.

Clinical trials (London, England)·2024
Same author

Testosterone Therapy in Men After Radical Prostatectomy for Low-Intermediate Organ-Confined Prostate Cancer.

The Journal of urology·2024
Same author

Re: Early Prostate Cancer Deaths Among Men with Higher vs Lower Genetic Risk.

European urology·2024
Same author

Transperineal vs Transrectal Prostate Biopsy-The PREVENT Randomized Clinical Trial.

JAMA oncology·2024
Same author

Clinical utility of an artificial intelligence radiomics-based tool for risk stratification of pulmonary nodules.

JNCI cancer spectrum·2024

Related Experiment Video

Updated: Jul 20, 2025

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

7.8K

The Association Between Low Preoperative Serum Testosterone and Post-radical Prostatectomy Urinary Function.

M Paula Domino1, Emily A Vertosick2, Andrew J Vickers2

  • 1Voiding Dysfunction and Reconstructive Surgery, University of Mississippi Medical Center, Jackson, MS.

Urology
|July 29, 2023
PubMed
Summary

This study found no significant link between low testosterone (hypogonadism) and delayed urinary function recovery after radical prostatectomy. Preoperative testosterone levels did not adversely impact continence outcomes in patients undergoing the procedure.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.1K
Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
07:17

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

8.1K

Related Experiment Videos

Last Updated: Jul 20, 2025

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

7.8K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.1K
Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
07:17

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

8.1K

Area of Science:

  • Urology
  • Endocrinology
  • Oncology

Background:

  • Radical prostatectomy (RP) can impact urinary function.
  • Hypogonadism, or low testosterone, is common and may affect recovery.
  • Preoperative factors can influence post-prostatectomy outcomes.

Purpose of the Study:

  • To investigate if hypogonadism delays urinary function recovery after RP.
  • To assess the impact of preoperative testosterone levels on urinary continence post-RP.

Main Methods:

  • Retrospective analysis of 1209 patients undergoing RP.
  • Assessed association between low preoperative testosterone (≤300 ng/dL) and urinary continence at 6 and 12 months.
  • Used logistic regression adjusted for age and nerve-sparing status.

Main Results:

  • No significant association found between low testosterone and impaired urinary continence at 6 or 12 months post-RP.
  • Continence rates were nonsignificantly lower at 6 months and nonsignificantly higher at 12 months in men with low testosterone.
  • Sensitivity analyses confirmed these findings, even when excluding certain patient groups.

Conclusions:

  • Low serum testosterone does not appear to adversely affect urinary function recovery after radical prostatectomy.
  • Findings can inform patient counseling, particularly for those in neoadjuvant androgen deprivation therapy (ADT) trials or with prior ADT.
  • Further research may explore potential subtle effects on early continence.